[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
RedChip @RedChip on x 5590 followers
Created: 2025-07-18 13:20:01 UTC
🎙️ Investor Spotlight: Enlivex Therapeutics $ENLV CEO Shares Game Changing Vision in New Interview
Oren Hershkovitz, CEO of @EnlivexT, dives into the company’s innovative approach to immunotherapy with Allocetra™, a macrophage reprogramming cell therapy targeting high-need indications like osteoarthritis and autoimmune diseases.
💡 Why Investors Should Watch: 🔬 Strong Clinical Data: Statistically significant 6-month results in knee osteoarthritis show sustained pain reduction and functional gains. 💰 High-Value Pipeline: Expansion into basal thumb osteoarthritis and psoriatic arthritis unlocks multi-billion-dollar market potential. 🧠Proven Leadership: Team led a $560M exit (PROLOR Biotech) and holds strategic ties with Pfizer. 💵 Cash Runway: Funded through 2026 with analyst price targets up to $9.50/share.
📽️ Don’t miss this exclusive look into $ENLV's path to redefining chronic disease treatment. 🔗 Watch the full interview here:
$ENLV $JNJ $ABBV $MRK $AZN #ENLV #BiotechStocks #Immunotherapy #HealthcareInnovation #Osteoarthritis #ClinicalTrials #InvestorUpdate #PharmaNews
XX engagements
Related Topics stocks $enlv investment $issc